位置:首页 > 蛋白库 > CRTC1_HUMAN
CRTC1_HUMAN
ID   CRTC1_HUMAN             Reviewed;         634 AA.
AC   Q6UUV9; A6NMG5; O75114; Q6Y3A3; Q7LDZ2; Q8IUL3; Q8IZ34; Q8IZL1; Q8N6W3;
AC   Q96AI8; Q9H801;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 2.
DT   03-AUG-2022, entry version 156.
DE   RecName: Full=CREB-regulated transcription coactivator 1;
DE   AltName: Full=Mucoepidermoid carcinoma translocated protein 1;
DE   AltName: Full=Transducer of regulated cAMP response element-binding protein 1;
DE            Short=TORC-1;
DE            Short=Transducer of CREB protein 1;
GN   Name=CRTC1 {ECO:0000312|HGNC:HGNC:16062};
GN   Synonyms=KIAA0616 {ECO:0000312|EMBL:BAA31591.1},
GN   MECT1 {ECO:0000312|HGNC:HGNC:16062}, TORC1 {ECO:0000312|EMBL:AAQ98856.1},
GN   WAMTP1 {ECO:0000303|PubMed:14720503};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAQ98856.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), FUNCTION, AND INTERACTION
RP   WITH CREB1.
RX   PubMed=14506290; DOI=10.1073/pnas.1932773100;
RA   Iourgenko V., Zhang W., Mickanin C., Daly I., Jiang C., Hexham J.M.,
RA   Orth A.P., Miraglia L., Meltzer J., Garza D., Chirn G.-W., McWhinnie E.,
RA   Cohen D., Skelton J., Terry R., Yu Y., Bodian D., Buxton F.P., Zhu J.,
RA   Song C., Labow M.A.;
RT   "Identification of a family of cAMP response element-binding protein
RT   coactivators by genome-scale functional analysis in mammalian cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12147-12152(2003).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAK93832.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND CHROMOSOMAL TRANSLOCATION WITH
RP   MAML2.
RX   PubMed=12539049; DOI=10.1038/ng1083;
RA   Tonon G., Modi S., Wu L., Kubo A., Coxon A.B., Komiya T., O'Neil K.,
RA   Stover K., El-Naggar A., Griffin J.D., Kirsch I.R., Kaye F.J.;
RT   "t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a
RT   novel fusion product that disrupts a Notch signaling pathway.";
RL   Nat. Genet. 33:208-213(2003).
RN   [3]
RP   ERRATUM OF PUBMED:12539049.
RA   Tonon G., Modi S., Wu L., Kubo A., Coxon A.B., Komiya T., O'Neil K.,
RA   Stover K., El-Naggar A., Griffin J.D., Kirsch I.R., Kaye F.J.;
RL   Nat. Genet. 33:408-408(2003).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:BAB14822.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Embryo {ECO:0000312|EMBL:BAB14822.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAC97072.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000305, ECO:0000312|EMBL:AAH28050.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS ILE-311
RP   AND ALA-328.
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH28050.1}, Colon, and
RC   Eye {ECO:0000312|EMBL:AAH23614.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305, ECO:0000312|EMBL:AAP12463.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-104 (ISOFORMS 1/3), TISSUE SPECIFICITY, AND
RP   CHROMOSOMAL TRANSLOCATION WITH MAML2.
RC   TISSUE=Carcinoma {ECO:0000269|PubMed:14720503};
RX   PubMed=14720503; DOI=10.1016/j.yexcr.2003.09.007;
RA   Enlund F., Behboudi A., Andren Y., Oberg C., Lendahl U., Mark J.,
RA   Stenman G.;
RT   "Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene
RT   fusion in mucoepidermoid carcinomas and benign Warthin's tumors.";
RL   Exp. Cell Res. 292:21-28(2004).
RN   [9] {ECO:0000305, ECO:0000312|EMBL:BAA31591.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 17-634 (ISOFORM 2).
RC   TISSUE=Brain {ECO:0000312|EMBL:BAA31591.1};
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [10] {ECO:0000305}
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH CREB1 AND TAF4.
RX   PubMed=14536081; DOI=10.1016/j.molcel.2003.08.013;
RA   Conkright M.D., Canettieri G., Screaton R., Guzman E., Miraglia L.,
RA   Hogenesch J.B., Montminy M.;
RT   "TORCs: transducers of regulated CREB activity.";
RL   Mol. Cell 12:413-423(2003).
RN   [11]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=15589160; DOI=10.1016/j.cub.2004.11.002;
RA   Bittinger M.A., McWhinnie E., Meltzer J., Iourgenko V., Latario B., Liu X.,
RA   Chen C.H., Song C., Garza D., Labow M.;
RT   "Activation of cAMP response element-mediated gene expression by regulated
RT   nuclear transport of TORC proteins.";
RL   Curr. Biol. 14:2156-2161(2004).
RN   [12] {ECO:0000305}
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=15729701; DOI=10.1002/gcc.20168;
RA   Behboudi A., Winnes M., Gorunova L., van den Oord J.J., Mertens F.,
RA   Enlund F., Stenman G.;
RT   "Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)-
RT   associated TORC1-MAML2 gene fusion.";
RL   Genes Chromosomes Cancer 43:202-205(2005).
RN   [13]
RP   FUNCTION, PHOSPHORYLATION AT SER-151, AND SUBCELLULAR LOCATION.
RX   PubMed=16817901; DOI=10.1111/j.1742-4658.2006.05291.x;
RA   Katoh Y., Takemori H., Lin X.-Z., Tamura M., Muraoka M., Satoh T.,
RA   Tsuchiya Y., Min L., Doi J., Miyauchi A., Witters L.A., Nakamura H.,
RA   Okamoto M.;
RT   "Silencing the constitutive active transcription factor CREB by the LKB1-
RT   SIK signaling cascade.";
RL   FEBS J. 273:2730-2748(2006).
RN   [14]
RP   INTERACTION WITH HTLV-1 TAX (MICROBIAL INFECTION), AND FUNCTION (MICROBIAL
RP   INFECTION).
RX   PubMed=16809310; DOI=10.1128/jvi.00103-06;
RA   Siu Y.-T., Chin K.-T., Siu K.-L., Yee Wai Choy E., Jeang K.-T., Jin D.-Y.;
RT   "TORC1 and TORC2 coactivators are required for tax activation of the human
RT   T-cell leukemia virus type 1 long terminal repeats.";
RL   J. Virol. 80:7052-7059(2006).
RN   [15]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16980408; DOI=10.1073/pnas.0606714103;
RA   Wu Z., Huang X., Feng Y., Handschin C., Feng Y., Gullicksen P.S., Bare O.,
RA   Labow M., Spiegelman B., Stevenson S.C.;
RT   "Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha
RT   transcription and mitochondrial biogenesis in muscle cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14379-14384(2006).
RN   [16]
RP   FUNCTION.
RX   PubMed=17210223; DOI=10.1016/j.mce.2006.12.020;
RA   Takemori H., Kanematsu M., Kajimura J., Hatano O., Katoh Y., Lin X.-Z.,
RA   Min L., Yamazaki T., Doi J., Okamoto M.;
RT   "Dephosphorylation of TORC initiates expression of the StAR gene.";
RL   Mol. Cell. Endocrinol. 265:196-204(2007).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   FUNCTION.
RX   PubMed=23699513; DOI=10.1523/jneurosci.4202-12.2013;
RA   Sakamoto K., Norona F.E., Alzate-Correa D., Scarberry D., Hoyt K.R.,
RA   Obrietan K.;
RT   "Clock and light regulation of the CREB coactivator CRTC1 in the
RT   suprachiasmatic circadian clock.";
RL   J. Neurosci. 33:9021-9027(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   INTERACTION WITH YWHAE AND PPP3CA, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=30611118; DOI=10.1016/j.isci.2018.12.012;
RA   Sonntag T., Ostojic J., Vaughan J.M., Moresco J.J., Yoon Y.S.,
RA   Yates J.R. III, Montminy M.;
RT   "Mitogenic Signals Stimulate the CREB Coactivator CRTC3 through PP2A
RT   Recruitment.";
RL   IScience 11:134-145(2018).
CC   -!- FUNCTION: Transcriptional coactivator for CREB1 which activates
CC       transcription through both consensus and variant cAMP response element
CC       (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway,
CC       being active when dephosphorylated and acts independently of CREB1
CC       'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4.
CC       Regulates the expression of specific CREB-activated genes such as the
CC       steroidogenic gene, StAR. Potent coactivator of PGC1alpha and inducer
CC       of mitochondrial biogenesis in muscle cells. In the hippocampus,
CC       involved in late-phase long-term potentiation (L-LTP) maintenance at
CC       the Schaffer collateral-CA1 synapses. May be required for dendritic
CC       growth of developing cortical neurons (By similarity). In concert with
CC       SIK1, regulates the light-induced entrainment of the circadian clock.
CC       In response to light stimulus, coactivates the CREB-mediated
CC       transcription of PER1 which plays an important role in the photic
CC       entrainment of the circadian clock. {ECO:0000250|UniProtKB:Q157S1,
CC       ECO:0000250|UniProtKB:Q68ED7, ECO:0000269|PubMed:23699513}.
CC   -!- FUNCTION: (Microbial infection) Plays a role of coactivator for TAX
CC       activation of the human T-cell leukemia virus type 1 (HTLV-1) long
CC       terminal repeats (LTR). {ECO:0000269|PubMed:16809310}.
CC   -!- SUBUNIT: Binds, as a tetramer, through its N-terminal region, with the
CC       bZIP domain of CREB1 (PubMed:14536081). 'Arg-314' in the bZIP domain of
CC       CREB1 is essential for this interaction (PubMed:14536081). Interaction,
CC       via its C-terminal, with TAF4, enhances recruitment of TAF4 to CREB1
CC       (PubMed:14536081). Interacts with 14-3-3 proteins, including YWHAE/14-
CC       3-3 epsilon (PubMed:30611118). Interacts with calmodulin-dependent
CC       catalytic subunit PPP3CA/calcineurin A (PubMed:30611118).
CC       {ECO:0000269|PubMed:14536081, ECO:0000269|PubMed:30611118}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HTLV1 Tax.
CC       {ECO:0000269|PubMed:16809310}.
CC   -!- INTERACTION:
CC       Q6UUV9; P16220: CREB1; NbExp=6; IntAct=EBI-1644259, EBI-711855;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15589160}. Nucleus
CC       {ECO:0000269|PubMed:15589160}. Note=Cytoplasmic when phosphorylated by
CC       SIK or AMPK and when sequestered by 14-3-3 proteins (PubMed:16817901).
CC       Translocated to the nucleus on Ser-151 dephosphorylation, instigated by
CC       a number of factors including calcium ion and cAMP levels
CC       (PubMed:15589160). Light stimulation triggers a nuclear accumulation in
CC       the suprachiasmatic nucleus (SCN) of the brain (By similarity).
CC       {ECO:0000250|UniProtKB:Q68ED7, ECO:0000269|PubMed:15589160,
CC       ECO:0000269|PubMed:16817901}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:14506290};
CC         IsoId=Q6UUV9-1; Sequence=Displayed;
CC       Name=2 {ECO:0000305};
CC         IsoId=Q6UUV9-2; Sequence=VSP_051749;
CC       Name=3 {ECO:0000269|PubMed:12539049};
CC         IsoId=Q6UUV9-3; Sequence=VSP_051750, VSP_051751;
CC   -!- TISSUE SPECIFICITY: Highly expressed in adult and fetal brain. Located
CC       to specific regions such as the prefrontal cortex and cerebellum. Very
CC       low expression in other tissues such as heart, spleen, lung, skeletal
CC       muscle, salivary gland, ovary and kidney. {ECO:0000269|PubMed:14720503,
CC       ECO:0000269|PubMed:16980408}.
CC   -!- PTM: Phosphorylation/dephosphorylation states of Ser-151 are required
CC       for regulating transduction of CREB activity. TORCs are inactive when
CC       phosphorylated, and active when dephosphorylated at this site. This
CC       primary site of phosphorylation is mediated by SIKs (SIK1 and SIK2), is
CC       regulated by cAMP and calcium levels and is dependent on the
CC       phosphorylation of SIKs by LKB1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q68ED7}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CRTC1 is found in
CC       mucoepidermoid carcinomas, benign Warthin tumors and clear cell
CC       hidradenomas. Translocation t(11;19)(q21;p13) with MAML2. The fusion
CC       protein consists of the N-terminus of CRTC1 joined to the C-terminus of
CC       MAML2. The reciprocal fusion protein consisting of the N-terminus of
CC       MAML2 joined to the C-terminus of CRTC1 has been detected in a small
CC       number of mucoepidermoid carcinomas.
CC   -!- SIMILARITY: Belongs to the TORC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH17075.3; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH23614.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAP12463.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CRTC1ID471ch19p13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY360171; AAQ98856.1; -; mRNA.
DR   EMBL; AY040323; AAK93832.1; -; mRNA.
DR   EMBL; AY040324; AAK93833.1; ALT_TERM; mRNA.
DR   EMBL; AK024089; BAB14822.1; -; mRNA.
DR   EMBL; AC003107; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004476; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006123; AAC97072.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84730.1; -; Genomic_DNA.
DR   EMBL; BC017075; AAH17075.3; ALT_INIT; mRNA.
DR   EMBL; BC023614; AAH23614.2; ALT_INIT; mRNA.
DR   EMBL; BC028050; AAH28050.1; -; mRNA.
DR   EMBL; AB014516; BAA31591.1; -; mRNA.
DR   EMBL; AY186997; AAP12462.1; ALT_TERM; mRNA.
DR   EMBL; AY186998; AAP12463.1; ALT_INIT; mRNA.
DR   CCDS; CCDS32963.1; -. [Q6UUV9-1]
DR   CCDS; CCDS42525.1; -. [Q6UUV9-2]
DR   PIR; T00388; T00388.
DR   RefSeq; NP_001091952.1; NM_001098482.1. [Q6UUV9-2]
DR   RefSeq; NP_056136.2; NM_015321.2. [Q6UUV9-1]
DR   PDB; 7D8H; X-ray; 2.42 A; B=59-69.
DR   PDB; 7D8P; X-ray; 2.00 A; C/D=146-156.
DR   PDB; 7D9V; X-ray; 2.21 A; C/D=240-250.
DR   PDBsum; 7D8H; -.
DR   PDBsum; 7D8P; -.
DR   PDBsum; 7D9V; -.
DR   AlphaFoldDB; Q6UUV9; -.
DR   SMR; Q6UUV9; -.
DR   BioGRID; 116952; 23.
DR   IntAct; Q6UUV9; 10.
DR   STRING; 9606.ENSP00000345001; -.
DR   GlyGen; Q6UUV9; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q6UUV9; -.
DR   PhosphoSitePlus; Q6UUV9; -.
DR   BioMuta; CRTC1; -.
DR   DMDM; 68565585; -.
DR   EPD; Q6UUV9; -.
DR   jPOST; Q6UUV9; -.
DR   MassIVE; Q6UUV9; -.
DR   MaxQB; Q6UUV9; -.
DR   PaxDb; Q6UUV9; -.
DR   PeptideAtlas; Q6UUV9; -.
DR   PRIDE; Q6UUV9; -.
DR   ProteomicsDB; 67426; -. [Q6UUV9-1]
DR   ProteomicsDB; 67427; -. [Q6UUV9-2]
DR   ProteomicsDB; 67428; -. [Q6UUV9-3]
DR   Antibodypedia; 15141; 380 antibodies from 41 providers.
DR   DNASU; 23373; -.
DR   Ensembl; ENST00000321949.13; ENSP00000323332.7; ENSG00000105662.16. [Q6UUV9-1]
DR   Ensembl; ENST00000338797.10; ENSP00000345001.5; ENSG00000105662.16. [Q6UUV9-2]
DR   GeneID; 23373; -.
DR   KEGG; hsa:23373; -.
DR   MANE-Select; ENST00000321949.13; ENSP00000323332.7; NM_015321.3; NP_056136.2.
DR   UCSC; uc002nkb.5; human. [Q6UUV9-1]
DR   CTD; 23373; -.
DR   DisGeNET; 23373; -.
DR   GeneCards; CRTC1; -.
DR   HGNC; HGNC:16062; CRTC1.
DR   HPA; ENSG00000105662; Low tissue specificity.
DR   MIM; 607536; gene.
DR   neXtProt; NX_Q6UUV9; -.
DR   OpenTargets; ENSG00000105662; -.
DR   PharmGKB; PA30730; -.
DR   VEuPathDB; HostDB:ENSG00000105662; -.
DR   eggNOG; ENOG502QU41; Eukaryota.
DR   GeneTree; ENSGT00390000010652; -.
DR   HOGENOM; CLU_019357_2_0_1; -.
DR   InParanoid; Q6UUV9; -.
DR   OMA; FNMVEGA; -.
DR   OrthoDB; 1118500at2759; -.
DR   PhylomeDB; Q6UUV9; -.
DR   TreeFam; TF321571; -.
DR   PathwayCommons; Q6UUV9; -.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-9707616; Heme signaling.
DR   SignaLink; Q6UUV9; -.
DR   SIGNOR; Q6UUV9; -.
DR   BioGRID-ORCS; 23373; 18 hits in 1079 CRISPR screens.
DR   ChiTaRS; CRTC1; human.
DR   GeneWiki; CRTC1; -.
DR   GenomeRNAi; 23373; -.
DR   Pharos; Q6UUV9; Tbio.
DR   PRO; PR:Q6UUV9; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q6UUV9; protein.
DR   Bgee; ENSG00000105662; Expressed in type B pancreatic cell and 152 other tissues.
DR   ExpressionAtlas; Q6UUV9; baseline and differential.
DR   Genevisible; Q6UUV9; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; IDA:UniProtKB.
DR   GO; GO:0097009; P:energy homeostasis; IEA:Ensembl.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:1902631; P:negative regulation of membrane hyperpolarization; IEA:Ensembl.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:1900006; P:positive regulation of dendrite development; IEA:Ensembl.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0099527; P:postsynapse to nucleus signaling pathway; IEA:Ensembl.
DR   GO; GO:0051289; P:protein homotetramerization; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   InterPro; IPR024786; TORC.
DR   InterPro; IPR024785; TORC_C.
DR   InterPro; IPR024784; TORC_M.
DR   InterPro; IPR024783; TORC_N.
DR   PANTHER; PTHR13589; PTHR13589; 1.
DR   Pfam; PF12886; TORC_C; 1.
DR   Pfam; PF12885; TORC_M; 1.
DR   Pfam; PF12884; TORC_N; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Biological rhythms;
KW   Chromosomal rearrangement; Cytoplasm; Host-virus interaction; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..634
FT                   /note="CREB-regulated transcription coactivator 1"
FT                   /id="PRO_0000096354"
FT   REGION          110..174
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          191..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          258..331
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          357..479
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           242..258
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        110..124
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        142..174
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        194..212
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        269..284
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        296..331
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        362..396
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        404..429
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        443..479
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            42..43
FT                   /note="Breakpoint for translocation to form the MECT1-MAML2
FT                   and MAML2-MECT1 fusion proteins"
FT                   /evidence="ECO:0000269|PubMed:12539049,
FT                   ECO:0000269|PubMed:14720503"
FT   SITE            575
FT                   /note="Required for ubiquitination and degradation"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         64
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68ED7"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         149
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68ED7"
FT   MOD_RES         151
FT                   /note="Phosphoserine; by SIK1 and SIK2"
FT                   /evidence="ECO:0000269|PubMed:16817901"
FT   MOD_RES         161
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VAR_SEQ         81
FT                   /note="Q -> QPSGFLGEALAAAPVSL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14506290,
FT                   ECO:0000303|PubMed:9734811"
FT                   /id="VSP_051749"
FT   VAR_SEQ         475..503
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12539049,
FT                   ECO:0000303|PubMed:14506290, ECO:0000303|PubMed:14702039"
FT                   /id="VSP_051750"
FT   VAR_SEQ         580..634
FT                   /note="SLAGVGDVSFDSDSQFPLDELKIDPLTLDGLHMLNDPDMVLADPATEDTFRM
FT                   DRL -> HRGHLPDGPPVSGHAGTLPLSRPDGASPARGRPCSVPRQRPSL (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12539049,
FT                   ECO:0000303|PubMed:14506290, ECO:0000303|PubMed:14702039"
FT                   /id="VSP_051751"
FT   VARIANT         286
FT                   /note="T -> A (in dbSNP:rs3746266)"
FT                   /id="VAR_053934"
FT   VARIANT         311
FT                   /note="V -> I (in dbSNP:rs36070283)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_053935"
FT   VARIANT         328
FT                   /note="T -> A (in dbSNP:rs3746266)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_053936"
FT   CONFLICT        84
FT                   /note="F -> S (in Ref. 4; BAB14822)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        384
FT                   /note="P -> S (in Ref. 4; BAB14822)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        556
FT                   /note="S -> G (in Ref. 4; BAB14822)"
FT                   /evidence="ECO:0000305"
FT   HELIX           152..155
FT                   /evidence="ECO:0007829|PDB:7D8P"
SQ   SEQUENCE   634 AA;  67300 MW;  ECDC427FF9D6920B CRC64;
     MATSNNPRKF SEKIALHNQK QAEETAAFEE VMKDLSLTRA ARLQLQKSQY LQLGPSRGQY
     YGGSLPNVNQ IGSGTMDLPF QTPFQSSGLD TSRTTRHHGL VDRVYRERGR LGSPHRRPLS
     VDKHGRQADS CPYGTMYLSP PADTSWRRTN SDSALHQSTM TPTQPESFSS GSQDVHQKRV
     LLLTVPGMEE TTSEADKNLS KQAWDTKKTG SRPKSCEVPG INIFPSADQE NTTALIPATH
     NTGGSLPDLT NIHFPSPLPT PLDPEEPTFP ALSSSSSTGN LAANLTHLGI GGAGQGMSTP
     GSSPQHRPAG VSPLSLSTEA RRQQASPTLS PLSPITQAVA MDALSLEQQL PYAFFTQAGS
     QQPPPQPQPP PPPPPASQQP PPPPPPQAPV RLPPGGPLLP SASLTRGPQP PPLAVTVPSS
     LPQSPPENPG QPSMGIDIAS APALQQYRTS AGSPANQSPT SPVSNQGFSP GSSPQHTSTL
     GSVFGDAYYE QQMAARQANA LSHQLEQFNM MENAISSSSL YSPGSTLNYS QAAMMGLTGS
     HGSLPDSQQL GYASHSGIPN IILTVTGESP PSLSKELTSS LAGVGDVSFD SDSQFPLDEL
     KIDPLTLDGL HMLNDPDMVL ADPATEDTFR MDRL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024